Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase IIa data for multiple doses of GSK-3389404 in chronic HBV on stable nucleos(t)ide therapy

Nov. 12, 2019

Medshine Discovery identifies new LRRK2 inhibitors

Nov. 12, 2019

Baylor College of Medicine, Tvardi Therapeutics patent STAT3 inhibitors

Nov. 12, 2019

Dopamine D1 receptor positive allosteric modulators discovered at Lilly

Nov. 12, 2019

Seres Therapeutics discloses bacterial compositions

Nov. 12, 2019

Emergex Vaccines descibes new filovirus vaccines

Nov. 12, 2019

HOOKIPA Pharma presents phase I data for CMV vaccine HB-101

Nov. 12, 2019

ALBI as a promising prognostic marker in predicting survival from HCC

Nov. 12, 2019

MRX-1669, a novel small-molecule Myc inhibitor with promising in vitro activity

Nov. 12, 2019

SAR-20351 demonstrates promising safety and efficacy in syngeneic tumor models

Nov. 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...